News
Pharmaterials rebrands to Quotient Sciences
Quotient Sciences announces that it has completed the integration and rebrand of Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K.
Quotient is your answer.
Quotient is your answer.
We are dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development services, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
-
How do I accelerate my molecule to proof-of-concept?
Learn moreLearn more
Quotient is your answer.
How do I accelerate my molecule to proof-of-concept?
Learn more -
How do I optimize my formulation?
Learn moreLearn more
Quotient is your answer.
How do I optimize my formulation?
Learn more -
How do I optimize and scale up my manufacturing process for the later stages of development and commercial launch?
Learn moreLearn more
Quotient is your answer.
How do I optimize and scale up my manufacturing process for the later stages of development and commercial launch?
Learn more -
How do I efficiently plan and execute my regulatory clinical pharmacology studies?
Learn moreLearn more
Quotient is your answer.
How do I efficiently plan and execute my regulatory clinical pharmacology studies?
Learn more -
How do I develop age-appropriate drug products for pediatric populations?
Learn moreLearn more
Quotient is your answer.
How do I develop age-appropriate drug products for pediatric populations?
Learn more
Our latest updates
Discover what’s happening at Quotient Sciences
-
Fact Sheet
Formulation development
From preclinical and first-in-human (FIH) dosage forms to optimization of your drug products for late stage development, we work with you to develop the most appropriate formulation.
-
News
Quotient Sciences and PPD Form Innovative Partnership to Accelerate Pediatric Drug Development
The collaboration simplifies contracting and delivery by offering clients a single solution for an entire pediatric program, with only one contract and one PPD point of contact. As a result of that structure, the number of handoffs is significantly reduced and the process is much more streamlined, eliminating the delays that often occur when moving from early dosing to later phases.